|
NR2C1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.267900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.253800E-02 |
| Normal-vs-Stage2 |
6.718800E-01 |
| Normal-vs-Stage3 |
9.590600E-01 |
| Normal-vs-Stage4 |
9.328200E-02 |
| Stage1-vs-Stage2 |
5.427200E-01 |
| Stage1-vs-Stage3 |
1.638000E-01 |
| Stage1-vs-Stage4 |
3.280600E-03 |
| Stage2-vs-Stage3 |
7.190600E-01 |
| Stage2-vs-Stage4 |
1.115800E-01 |
| Stage3-vs-Stage4 |
2.090400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.089800E-02 |
| Normal-vs-AfricanAmerican |
1.121430E-01 |
| Normal-vs-Asian |
6.521200E-01 |
| Caucasian-vs-AfricanAmerican |
8.766200E-01 |
| Caucasian-vs-Asian |
4.467800E-01 |
| AfricanAmerican-vs-Asian |
3.644000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.108000E-02 |
| Normal-vs-Female |
5.875600E-02 |
| Male-vs-Female |
7.169400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.196200E-01 |
| Normal-vs-Extreme_Weight |
7.132000E-01 |
| Normal-vs-Obese |
7.819900E-02 |
| Normal-vs-Extreme_Obese |
5.676800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.346800E-01 |
| Normal_Weight-vs-Obese |
4.490200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.100200E-01 |
| Extreme_Weight-vs-Obese |
1.644380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.800600E-01 |
| Obese-vs-Extreme_Obese |
2.232400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.903600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.697100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.836000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.466360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.331000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.468640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.162330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.709800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.943930E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.993010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.773800E-04 |
| Normal-VS-Type2 PRCC |
9.225700E-02 |
| Normal-VS-KIRP CIMP |
9.067400E-01 |
| Normal-VS-Unclassified PRCC |
4.187200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.11459999972008E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.440580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.630300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.624400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.878300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.869400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.485800E-01 |
| Normal-vs-N1 |
4.372200E-01 |
| Normal-vs-N2 |
3.415000E-01 |
| N0-vs-N1 |
3.488200E-01 |
| N0-vs-N2 |
5.547600E-01 |
| N1-vs-N2 |
4.171000E-01 |
|
|
